Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Vehicle-Controlled Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Preliminary Efficacy of CU-10101 Unguent in Healthy and AD Participants

NCT06744569 is registered in ClinicalTrials.gov with Cutia Therapeutics（Wuxi）Co.,Ltd as lead sponsor.

NCT NCT06744569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06744569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Vehicle-Controlled Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Preliminary Efficacy of CU-10101 Unguent in Healthy and AD Participants
Lead sponsor
Cutia Therapeutics（Wuxi）Co.,Ltd
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
September 12, 2024
Completion date
September 9, 2026
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis